tirzepatide causing headaches with and migraines: can GLP-1 drugs trigger or prevent them? Tirzepatide Headaches: Causes, Biomarkers & – GLP1/trizipatide for chronic migraines relief?

Potenza 4 mg / 3 ml Ozempic 1 mg

doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

Serious adverse events occurred in 2.8% of participants in the SURPASS-2 study, which is less frequent than the 5.37% reported among tirzepatide users

0 +15

Pay attention to any unusual symptoms, and have quick sources of sugar nearby, such as juice or glucose tablets, in case of low blood sugar